India's drug regulator DCGI on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.
from Top Business News- News18.com
Read The Rest:timesnownews...
from Top Business News- News18.com
Read The Rest:timesnownews...
Approval to Vaccines 'Turning Point' in India's Fight Against Covid-19: Niti Aayog
Reviewed by Team Exprssnews
on
January 03, 2021
Rating:
No comments: